Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study

NCT05607745 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2022-11-07

No results posted yet for this study

Summary

There are several studies performed to reveal the linkage between diet, fecal microbiota, and obesity. Human fecal microbiota transplantations in this asset are still scarce. Therefore, this pilot study of FMT from lean to obese people with dietary counseling will increase the knowledge, whether FMT could play a role in the treatment of obesity and NAFLD. Our primary outcome is the changes in glucose metabolism by HOMA-IR.

Conditions

  • NAFLD
  • Fecal Microbiota
  • Gut Microbiota
  • Obesity
  • Dietary Habits
  • Diet
  • Fecal Microbiota Transplantation
  • Glucose Metabolism Disorders
  • Nutrition, Healthy

Interventions

OTHER

FMT and placebo

Similar healthy diet counseling is given to all participants in both FMT and placebo group. FMT to placebo is given in 2:1.

Sponsors & Collaborators

  • Helsinki University Central Hospital

    collaborator OTHER
  • Päijänne Tavastia Central Hospital

    collaborator OTHER
  • University of Helsinki

    collaborator OTHER
  • Kuopio University Hospital

    collaborator OTHER
  • Kuopio Research Institute of Exercise Medicine

    collaborator OTHER
  • University of Eastern Finland

    lead OTHER

Principal Investigators

  • Milla-Maria Tauriainen, MD · Kuopio University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-30
Primary Completion
2024-06-30
Completion
2026-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05607745 on ClinicalTrials.gov